Participant Safety
All clinical studies are conducted under rigorous safety protocols with oversight from Institutional Review Boards (IRBs) and the FDA. Adverse events are monitored and reported in accordance with regulatory requirements.
Privacy Protection
All information collected during the clinical study is kept strictly confidential in accordance with IRB guidelines and federal regulations (HIPAA). Personal identifying information is not shared without explicit consent. Study data is de-identified and used only for research purposes.
Informed Consent
All participants provide written informed consent after receiving comprehensive information about the study procedures, potential risks and benefits, and their rights as research participants. Participation is voluntary and participants may withdraw at any time.
Ongoing Support
Study participants receive ongoing support from the study team throughout their participation. The study team is available to answer questions, address concerns, and provide information about study procedures and follow-up requirements.

